Randomized phase II study of stereotactic body radiotherapy and interleukin-2 versus interleukin-2 in patients with metastatic melanoma

BACKGROUND: A pilot study of stereotactic body radiation therapy (SBRT) followed by high-dose interleukin-2 (IL-2) showed a higher than anticipated objective response rate (ORR) among patients with metastatic melanoma (MM). We performed a prospective randomized study to determine if the ORR of SBRT...

Descripción completa

Detalles Bibliográficos
Autores principales: Curti, Brendan, Crittenden, Marka, Seung, Steven K, Fountain, Christopher B, Payne, Roxanne, Chang, ShuChing, Fleser, Jessica, Phillips, Kimberly, Malkasian, Ian, Dobrunick, Lyn B, Urba, Walter J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259841/
https://www.ncbi.nlm.nih.gov/pubmed/32467299
http://dx.doi.org/10.1136/jitc-2020-000773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259841/
https://www.ncbi.nlm.nih.gov/pubmed/32467299
http://dx.doi.org/10.1136/jitc-2020-000773

Ejemplares similares